Literature DB >> 18514702

Pediatric soft tissue sarcomas.

David M Loeb1, Katherine Thornton, Ori Shokek.   

Abstract

Soft tissue sarcomas in children are rare. Approximately 850 to 900 children and adolescents are diagnosed each year with rhabdomyosarcoma (RMS) or a non-RMS soft tissue sarcoma (NRSTS). RMS is more common in children 14 years old and younger and NRSTS in adolescents and young adults. Infants get NRSTS, but their tumors constitute a distinctive set of histologies. Surgery is a major therapeutic modality and radiation plays a role. RMS is treated with adjuvant chemotherapy, whereas chemotherapy is reserved for the NRSTS that are high grade or unresectable. This review discusses the etiology, biology, and treatment of pediatric soft tissue sarcomas.

Entities:  

Mesh：

Year:  2008        PMID： 18514702      PMCID： PMC4273573          DOI： 10.1016/j.suc.2008.03.008

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN： 0039-6109            Impact factor:   2.741


  33 in total

1.  Postoperative nomogram for 12-year sarcoma-specific death.

Authors:  Michael W Kattan; Denis H Y Leung; Murray F Brennan
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 2.  Combined surgery and radiation therapy for limb preservation in soft tissue sarcoma of the extremity: the Massachusetts General Hospital experience.

Authors:  I J Spiro; A E Rosenberg; D Springfield; H Suit
Journal:  Cancer Invest       Date:  1995       Impact factor: 2.176

3.  Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.

Authors:  Fangyu Peng; Galina Rabkin; Otto Muzik
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

4.  Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.

Authors:  A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee
Journal:  J Clin Oncol       Date:  2002-11-15       Impact factor: 44.544

5.  Diagnosis of soft tissue tumours by Tru-Cut biopsy.

Authors:  A B Ball; C Fisher; M Pittam; R M Watkins; G Westbury
Journal:  Br J Surg       Date:  1990-07       Impact factor: 6.939

Review 6.  Amputation for soft-tissue sarcoma.

Authors:  Matthew A Clark; J Meirion Thomas
Journal:  Lancet Oncol       Date:  2003-06       Impact factor: 41.316

7.  Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma.

Authors:  H M McMulkin; N L Yanchar; C V Fernandez; C Giacomantonio
Journal:  Pediatr Surg Int       Date:  2003-05-10       Impact factor: 1.827

8.  Association of childhood rhabdomyosarcoma with neurofibromatosis type I and birth defects.

Authors:  P Yang; S Grufferman; M J Khoury; A G Schwartz; J Kowalski; F B Ruymann; H M Maurer
Journal:  Genet Epidemiol       Date:  1995       Impact factor: 2.135

9.  Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma.

Authors:  Andrea Ferrari; Rosalba Miceli; Michela Casanova; Alessandro Gronchi; Paola Collini; Cristina Meazza; Elena Zaffignani; Maura Massimino; Filippo Spreafico; Luigi Mariani
Journal:  Eur J Cancer       Date:  2007-10-30       Impact factor: 9.162

10.  A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses.

Authors:  R J Barth; M J Merino; D Solomon; J C Yang; A R Baker
Journal:  Surgery       Date:  1992-09       Impact factor: 3.982
View more
  35 in total

Review 1.  Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era.

Authors:  Rachel Phelan; Hesham Eissa; Kerri Becktell; Neel Bhatt; Matthew Kudek; Brandon Nuechterlein; Lauren Pommert; Ryuma Tanaka; K Scott Baker
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

2.  Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.

Authors:  Adrianne L Myers; Regan F Williams; Cathy Y Ng; Joseph E Hartwich; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

3.  Rapamycin-induced tumor vasculature remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation.

Authors:  Adrianne L Myers; W Shannon Orr; Jason W Denbo; Catherine Y Ng; Junfang Zhou; Yunyu Spence; Jianrong Wu; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2012-01       Impact factor: 2.545

4.  Drosophila and mammalian models uncover a role for the myoblast fusion gene TANC1 in rhabdomyosarcoma.

Authors:  Usha Avirneni-Vadlamudi; Kathleen A Galindo; Tiana R Endicott; Vera Paulson; Scott Cameron; Rene L Galindo
Journal:  J Clin Invest       Date:  2011-12-19       Impact factor: 14.808

5.  Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities.

Authors:  Chigusa Sawamura; Dempsey S Springfield; Karen J Marcus; Antonio R Perez-Atayde; Mark C Gebhardt
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

6.  Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.

Authors:  Maria De Salvo; Lavinia Raimondi; Serena Vella; Laura Adesso; Roberta Ciarapica; Federica Verginelli; Antonio Pannuti; Arianna Citti; Renata Boldrini; Giuseppe M Milano; Antonella Cacchione; Andrea Ferrari; Paola Collini; Angelo Rosolen; Gianni Bisogno; Rita Alaggio; Alessandro Inserra; Mattia Locatelli; Stefano Stifani; Isabella Screpanti; Lucio Miele; Franco Locatelli; Rossella Rota
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

Review 7.  Pediatric genitourinary tumors.

Authors:  Sharon M Castellino; Anibal R Martinez-Borges; Thomas W McLean
Journal:  Curr Opin Oncol       Date:  2009-05       Impact factor: 3.645

8.  Unusual association of alveolar rhabdomyosarcoma with pancreatic metastasis: emerging role of PET-CT in tumor staging.

Authors:  Priyanka Jha; Andreas M J Frölich; Beth McCarville; Oscar M Navarro; Paul Babyn; Robert Goldsby; Heike Daldrup-Link
Journal:  Pediatr Radiol       Date:  2010-02-24

9.  Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.

Authors:  Roberta Ciarapica; Elena Carcarino; Laura Adesso; Maria De Salvo; Giorgia Bracaglia; Pier Paolo Leoncini; Alessandra Dall'agnese; Federica Verginelli; Giuseppe M Milano; Renata Boldrini; Alessandro Inserra; Stefano Stifani; Isabella Screpanti; Victor E Marquez; Sergio Valente; Antonello Mai; Pier Lorenzo Puri; Franco Locatelli; Daniela Palacios; Rossella Rota
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430

Review 10.  Current management of pediatric soft tissue sarcomas.

Authors:  Surasak Sangkhathat
Journal:  World J Clin Pediatr       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.